Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

DocuSign Inc (DOCU.O)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (US$) Price Target (US$) Rating
2022-09-1656.5865.00Neutral
2022-12-0446.6052.00Neutral
2023-02-2064.4752.00Sell
2023-05-3156.4045.00Sell
2023-06-0957.0248.00Sell
2023-08-2748.2944.00Sell
2023-09-0752.1348.00Sell
2023-10-3038.7740.00Sell
2023-12-0747.4444.00Sell
2024-03-0753.5648.00Sell
2024-04-1258.9062.00Neutral
2024-06-0752.0556.00Neutral
2024-09-0556.9360.00Neutral
2024-12-06106.99100.00Neutral
2025-03-1485.7690.00Neutral
2025-04-1775.4285.00Neutral
2025-06-0592.9080.00Neutral
2025-09-0579.8685.00Neutral
2025-12-0565.6775.00Neutral

Disclosures

  • UBS Securities LLC makes a market in the securities and/or ADRs of this company.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.